sanofi-aventis - Comment

Document ID: FDA-2007-0614-0006
Document Type: Public Submission
Agency: Food And Drug Administration
Received Date: February 08 2008, at 10:07 AM Eastern Standard Time
Date Posted: February 10 2008, at 12:00 AM Eastern Standard Time
Comment Start Date: December 4 2007, at 12:00 AM Eastern Standard Time
Comment Due Date: February 19 2008, at 11:59 PM Eastern Standard Time
Tracking Number: 803aace3
View Document:  View as format xml

View Comment

Sanofi-aventis comments on the proposed rule, "Amendment to the Current Good Manufacturing Practice Regulations for Finished Pharmaceuticals; Companion Document to the Direct Final Rule." Brian E, Harvey, M.D., Ph.D, Sanofi-aventis ...comments on the proposed rule....

Attachments:

Sanofi-aventis - Comment

Title:
Sanofi-aventis - Comment

Abstract:
Brian E. Harvey, M.D. Ph.D., Sanofi-aventis ...comments on the proposed rule....

View Attachment: View as format pdf

Related Comments

    View All
Total: 21
The Williamsburg Group, LLC - Comment
Public Submission    Posted: 01/30/2008     ID: FDA-2007-0614-0003

Feb 19,2008 11:59 PM ET
Agalloco & Associates - Comment
Public Submission    Posted: 02/10/2008     ID: FDA-2007-0614-0004

Feb 19,2008 11:59 PM ET
sanofi-aventis - Comment
Public Submission    Posted: 02/10/2008     ID: FDA-2007-0614-0006

Feb 19,2008 11:59 PM ET
Abbott Laboratories - Comment
Public Submission    Posted: 02/10/2008     ID: FDA-2007-0614-0007

Feb 19,2008 11:59 PM ET
Compressed Gas Association/GAWDA - Comment
Public Submission    Posted: 02/20/2008     ID: FDA-2007-0614-0010

Feb 19,2008 11:59 PM ET